Physician profile
Andrew Bergersen
NPI 1063899250
$5,143.45
in general payments reported to CMS, 2019-2025
35 companies · $646 in 2025
The $646 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $147 · 2021: $760 · 2022: $814 · 2023: $1,718 · 2024: $931 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,673 · Travel and Lodging: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,673.44 |
| Travel and Lodging | $622.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $907.54 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $541.83 | 2019-2025 | Axonics |
| Coloplast Corp | $390.99 | 2020-2025 | Porges Coloplast, Speedicath, Altis |
| Axonics, INC. | $383.89 | 2022-2024 | Axonics |
| Medtronic, INC. | $332.57 | 2022-2024 | Interstim |
| Teleflex LLC | $308.87 | 2021-2022 | |
| Srs Medical Systems, INC. | $292.61 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $234.48 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $208.04 | 2024-2025 | Itind System |
| Convatec INC. | $152.07 | 2022-2023 | |
| Karl Storz Endoscopy-America | $150.00 | 2024 | Hopkins |
| Conmed Corporation | $138.08 | 2023 | Airseal |
| Agiliti Surgical, INC. | $129.61 | 2023 | Sonablate |
| Antares Pharma, INC. | $118.71 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Angiodynamics, INC. | $107.61 | 2025 | Nanoknife |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $106.29 | 2020-2025 | |
| Accord Healthcare, INC. | $87.67 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $84.17 | 2021-2025 | |
| Janssen Biotech, INC. | $80.95 | 2020-2024 | Erleada, Balversa, Akeega |
| Dendreon Pharmaceuticals LLC | $46.23 | 2023-2024 | Provenge |
| Merck Sharp & Dohme LLC | $43.81 | 2021-2024 | Keytruda |
| Myovant Sciences INC. | $42.11 | 2021-2022 | |
| Davol INC. | $40.11 | 2022 | |
| Caris Mpi, INC. | $24.20 | 2025 | Mi Cancer Seek |
| Cook Medical LLC | $22.59 | 2024 | Cook |
| 180 Medical, INC. | $22.26 | 2024 | Speedicath |
| Genzyme Corporation | $20.71 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $19.13 | 2024 | Bard Urinary Drainage Bag |
| Blue Earth Diagnostics | $18.70 | 2024 | |
| Calyxo, INC. | $15.68 | 2024 | Cvac Aspiration System |
| Tempus Ai, INC | $15.58 | 2025 | Xt Cdx |
| Tolmar, INC. | $15.44 | 2023 | |
| Sumitomo Pharma America, INC. | $14.11 | 2023 | Orgovyx |
| Astellas Pharma US INC | $13.71 | 2022 | |
| Ethicon US, LLC | $13.10 | 2023 | Harmonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Bergersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.